Infine, grazie a tutte le persone che mi hanno aiutata e sostenuta!!
Grazie, grazie, grazie!!!
Formattato: Inglese (Regno Unito)
BIBLIOGRAFIA
Ali-Osman F., Ankade O., Antoun G., Mao J. X., Buolamwini J. (1997), Molecular cloning, characterization and expression in Escherichia coli of full-lenght cDNAs of three human glutathione S-transferase π gene variants. Evidence for differential catalytic activity of the encoded proteins., J. Biol. Chem. 272, pp. 10004-10012.
Bailey, L. R., Roodi, N., Verrier, C. S., Yee, C. J., Dupont, W. D. and Parl, F. F. (1998), Breast cancer risk and CYP1A1, GSTM1 and GSTT1 polymorphisms: evidence of a lack of association in Caucasian and African Americans. Cancer Res. 58, pp. 65-70.
Boffetta, P., Kogevinas, M., Simonato, L., Wilbourn, J., Saracci, R. (1995) Int J Occup Environ Health. 1(4): 315-325.
Breslow NE, Storer BE. General relative risk functions for case-control studies. Am J Epidemiol. 1985 Jul;122(1):149-62.
Butkiewicz D., Grzybowska E., Phillips D. H., Hemminki K., Chorazy M. (2000), Polymorfisms of the GSTP1 and GSTM1 genes and PAH-DNA adducts in human mononuclear white blood cells. Environ. Mol. Mutagen. 35, pp. 99-105.
C.C. Harris (1989), Iterindividual variation among humans in carcinogen metabolism, DNA adduct formaion and DNA repair. Carcinogenesis 10, pp. 1563-1566.
Corrin, B., Otto, W.R., Wright, N.A. Stem cells in the lung. In Pathology of lung tumors. Churchill Livingstone, New York, (1997).
David P. Miller, Geoffrey Liu, Immaculata De Vivo, Thomas J. Lymch, John C. Wain, Li Su and David C. Christiani (2002), Combinations of the Variant Genotypes of GSTP1, GSTM1 and p53 are associated with an Increased Lung Cancer Risk. Cancer Res. 62, pp. 2819-2823.
Djordjevic, M.V., Hoffmann, D., Hoffmann, I. (1997) I. Prev Med 26,435-440.
Doll, R., Peto, R. (1981) J Natl Cancer Inst 66, 1191-1308.
Ernster, V. L. (1996) Annu. Rev. Public Health. 17, 97 - 114.
F. J. Gonzalez, C. L. Crespi and H. V. Gelboin (1991), DNA-expressed human cytocrome P450s: a new age of molecular toxicology and human risk assessment. Mutation Res. 247, pp.113-127.
Federica Gemignani, Victor Moreno, Stefano Landi, Norman Moullan, Amelie Chabrier, Sara Gutierrez-Enriquez, Janet Hall, Elisabeth Guino, Miguel Angel Peinado, Gabriel Capella, Federico Canzian (2004), Oncogene, 23, 1954-1956.
Fields W. R., Morrow C. S., Doss A. J., Sundberg K., Jernstrom B., Townsend A. J. (1998), Overexpression of stably transfected human glutathione S-transferase P1-1 protects against DNA damage by benzo(a)pyrene dio-epoxide in human T47D cell. Mol. Pharmacol. 54, pp. 298-304.
H. Raunio, K. Husgufvel-Pursiainen, S. Anttila, E. Hietanen, A. Hirvonen and O. Pelkonen (1995), Diagnosis of polymorfisms in carcinogen-activating and inactivating enzymes and cancer susceptibility- a review. Gene 159, pp. 113-121.
Hecht S.S. (1999), Tobacco smoke carcinogens and lung cancer. J. Natl. Cancer Inst. 91, pp. 1194-210.
Hoffmann, D., Hoffmann, I. (1995) I.Cancer Treat Res. 72,1-42.
Hoffmann, D., Hoffmann, I. (1997) J. Toxicol. Environ. Health. 50, 307 - 364.
Hoffmann ,D., Djordjevic, M.V., Hoffmann, I. (1997) Prev Med 26:427-434.
Hung RJ, Boffetta P, Canzian F, Moullan N, Szeszenia-Dabrowska N, Zaridze D, Lissowska J, Rudnai P, Fabianova E, Mates D, Foretova L, Janout V, Bencko V, Chabrier A, Landi S, Gemignani F, Hall J, Brennan P. (2006), Sequence Variants in Cell Cycle Control Pathway, X-ray Exposure, and Lung Cancer Risk: A Multicenter Case-Control Study in Central Europe. Cancer Res.66(16):8280-6.
IARC (International Agency for Research on Cancer) Cancer: (1990) Causes, Occurrence and Control.
IARC (International Agency for Research on Cancer) (1994) Occupational Cancer in Developing Countries.
J.J Mulvihill (1976), Host factors in human lun tumors: an example of ecogenetics in oncology. J. Natl. Cancer Inst. 57, pp 3-7.
J.F. Fraumeni, Jr. (1975) Respiratory carcinogenesis: an epidemiological appraisal. J. Natl. Cancer Inst. 55, pp. 1039-1046.
Joachim Schneider, Ulrike Bernges, Monika Philipp, Hans-Joachim Woitowitz (2004), Cancer Letters 208, pp. 65-74.
Kayser, K. Analytical Lung Pathology. Springer-Verlag, (1992) Berlin, Heidelberg, New York.
Kihara, M., Kihara, M., Noda, K., Okamoto, N. (1993). Cancer Lett. 71, pp. 151- 155.
Lung Cancer In: World Cancer Report, IARCPress 2003, Lyon France pp182-187.
Muller, K. M. Die Bronchialschleimhaut und das Bronkialkarzinom. (2000) Atemweg, Lungenerkrankungen. (370-374).
McWilliams, J. E., Sanderson, B. J,. Harris, E. L., Richert-Boe, K. E., Henner, W. D. (1995), Cancer Epidemiol. Biomarkers Prev. 4, pp. 589-594.
Nakajima T., Elovaara E., Anttila S., Hirvonen A., Camus A. M., Hayes J. D., Ketterer B., Vainio H. (1995), Expression of polymorfisms of glutathione S- transferase in human lungs: risk factors in smoking-related lung cancer. Carcinogenesis (Lond.) 16, pp.707-711.
Pamble, S., Schroeder, K. R., Spencer, S. R., Meyer, D. J., Hallier, E., Bolt, H. M., Ketterer, B. and Tayler, J. B. (1994). Human glutathione S-transferase theta (GSTT1): cDNA cloning and caracterization of a genetic polymorphism. Biochem. J. 300 (Part. 1), pp. 271-276.
Parkers, W. R. Occupational Lung Disorders. (1996) Butterworths, London 529 pp.
Parkin, D. M., Whelan, S. L., Ferlay, J., Raymond, L., Young, J. Eds (1997) Cancer Incidence in Five Continents, Vol. VII (IARC Scientific publication No.143 and IARC Cancerbase No.2), Lyon, IARCPress.
Peto, R., Darby, S., Deo, H., Silcocks, P., Whitley, E., Doll, R. (2000), Br. Med. J. 321, pp. 323-329.
Pinabasi, H., Silig, Y., Cetinkaya, O., Seyfikli, Z., Pinabasi, E. (2003), Cancer Genet. Cytogenet. 146, pp. 125-129.
Prescott, E., Osler, M., Andersen, P. K, Hein, H. O, Borch-Johnsen, K., Lange, P., Schnohr, P., Vestbo, J. (1998) Int. J. Epidemiol. 27, 27-32.
Randa El-Zein, Joseph B. Zwischenberger, Thomas G. Wood, Scherif Z. Abdel- Rahman, Chad Brekelbaum and William W. Au (1997), Combined genetic polymorfism and risk for development of lung cancer. Mut. Res./ Fund. and mol. mech. Of mutag., vol. 381, issue 2, pp. 189-200.
Risch, H. A, Howe, G. R, Jain, M., Burch, J. D., Holowaty, E.J., Miller, A.B. (1993) Am. J. Epidemiol. 138, 281 - 293.
Risch, H. A, Howe, G. R, Jain, M., Burch, J. D, Holowaty, E. J., Miller, A.B. (1994), Science 263, pp. 1206 -1208.
Ryberg D., Skaugh V., Hewer A., Phillips D. H., Harries L. W., Wolf C. R., Ogreid D., Ulvik A., Vu P., Haugen A. (1997), Genotypes of Glutathione transferase M1 and P1 and their significance for lung DNA adduct levels and cancer risk. Carcinogenesis (Lond.) 18, pp. 1285-1289.
Seidgard, J., Vorachek, W. R., Pero, R. W. and Pearson, W. R. (1988), Hereditary differences in the expression of the glutathione S- transferase activity on trans-stilbene oxid are due to a gene deletion. Proc. Natl. Acad. Sci. USA 85, pp. 7293-7297.
Shama C. Buch, Perin N. Notani e Rajani A. Bhisey (2002). Carcinogenesis, vol. no. 5, 803-807.
Shields, P. G.. (1999) Ann. Oncol,10 (Suppl.5): S7-S11.
Schoket, B., Philips, D. H., Kostic, S. and Vincze, I. (1998), Smoking-associated bulky DNA adducts in brinchial tissue related to CYP1A1 MspI and GSTM1 genotypes in lung patients. Carcinogenesis 19, pp. 841-846.
Simone Benhamou, Won Jin Lee, Anna-karin Alexandrie, Paolo Moffetta e altri (2002), Carcinogenesis, vol 23 no.8 ,1343-1350.
Strange, R.C. and Fryer, A. A. (1999), The glutathione S-transferase: influence of polymorphisms on cancer susceptibility. In: Metabolic Polymorphisms and
Susceptibility to Cancer. (Vineis, P., Malats, N., Lang, M., D’errico, A., Caporaso, N., Cuzick, J. And Boffetta, P., eds.). IARC Scientific Pubblication, No. 148, Lyon, France, pp. 231-249.
Strange, R.C., Spiteri, M. A., Ramachandran, S. and Fryer, A. A. (2001), Glutatione S-transferasi family of enzymes. Mut. Res. 482, pp. 21-26.
Thun, M. J, Lally, C. A, Flannery, J. T., Calle, E. E, Flanders, W. D., Heath, Jr C. W. (1997) J. Natl. Cancer Inst. 89,1580 -1586.
T.A. Sellers, J.E. Baily- Wilson, R.C. Elston, A.F. Wilson, G.Z. Elston, W.L. Ooi and H. Rotchild (1990), Evidence of Mendelian inheritance in the pathogenesis of lung cancer. J. Natl. Cancer Inst. 82, pp. 1272-1279.
T.A Sellers, J.D. Potter, J.E. Baily- Wilson, S.S. Rich, H. Rotschild and R.C. Eltson (1992), Lung cancer detection and prevention evidence for an interaction between smoking and genetic predisposition. Cancer Res. (Suppl.) 52, pp. 2694s-2698s.
Wang, Y., Liang, D., Spitz, M. R., Zhang, K., Dong, Q., Amos, C. I., Wu, X. (2003d), Cancer 98, pp. 1701-1706.
Watson M. A., Stewart R. K., Smith G. B., Massey T. E., Bell D. A. (1998), Human glutathione S-transferase P1 polymorphisms: relationship to lung tissue enzyme activity and population frequency distribution. Carcinogenesis (Lond.) 19, pp. 275-280.
Wingo, P. A, Ries, L. A, Giovino, G. A, Miller, D. S, Rosenberg, H.M., Shopland, D. R., Thun, M. J., Edwards, B. K. (1999) J. Natl. Cancer Inst. 91, 675-690.
Wu X, Zhao H, Amos CI, Shete S, Makan N, Hong WK, Kadlubar FF, Spitz MR. p53 Genotypes and Haplotypes Associated With Lung Cancer Susceptibility and Ethnicity. J Natl Cancer Inst. 2002 May 1;94(9):681-90.
Ye Z., Song H., Higgins JP, Pharoah P, Danesch J. (2006), Five glutathione s- transferase gene variants in 23,452 cases of lung cancer and 30,397 controls: meta- analysis of 130 studies. PLoS Med. 3(4):e91.
Zang, E. A., Wynder, E. L. (1996) J. Natl. Cancer Inst. 88, 183-192.
Zhong, S., Howie, A. F, Ketterer, B., Taylor, J., Hayes, J. D, Beckett, G. J., Wathen, C. G, Wolf, C. R, Spurr, N. K. (1991). Carcinogenesis. 12, pp. 1533-1537.